Danwang Medical Alternatives & Competitors

12 companies similar to Danwang Medical — Empowering medical advancements through regenerative medicine and organoid techn...

ORGANOIDSCIENCES 오가노이드사이언스

Commercialization of the world's first organoid treatment

44 Series B $26.02B

Korea South

Biopharma Biotechnology

Compare

Rznomics Inc.

Development of innovative treatments for cancer & intractable diseases through the RNA-bas...

11 Series C $59.70B

Korea South

Biopharma Biotechnology

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

8 Venture round $126.50M

Waltham, United States

Biopharma Biotechnology +3

VitroScan

Predictive Testing Solutions

10 Grant $2.70M

Leiden, The Netherlands

Biopharma Biotechnology +4

Track all Danwang Medical competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Olaris, Inc

Removing the Guesswork from Medicine

16 Series B

Framingham, United States

Biopharma Biotechnology +1

SonoThera

SonoThera is developing ultrasound-mediated nonviral genetic therapies.

54 Series A $60.75M

South San Francisco, Unit...

Biopharma Biotechnology

Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...

Series A $142.00M

Biopharma Biotechnology +1

KSQ Therapeutics, Inc.

The company is deploying CRISPRomics for novel drug development across broad therapeutic a...

60 Series C $166.00M

Lexington, United States

Biopharma Biotechnology +2

OrganoTherapeutics

Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disea...

9 $50.00K

Luxembourg

Biopharma Biotechnology +2

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

7 Seed $7.64M

Biopharma Biotechnology +1

DELIVER Therapeutics, Inc.

Applying high throughput screening technologies to deliver novel therapeutics

Houston, United States

Biopharma Biotechnology +1

Fusion Pharmaceuticals

Based in Hamilton, ON & Boston, MA, Fusion is developing next-generation radiopharmaceutic...

124 Post-IPO Equity $237.00M

Hamilton, Canada

Biopharma Biotechnology +1

About Danwang Medical

Danwang Medical is a biopharma and biotechnology startup founded in 2019 with the slogan "Empowering medical advancements through regenerative medicine and organoid technology for precise diagnostics and innovative therapies." The company specializes in advanced clinical transformation technology services in regenerati...

Business keywords

Regenerative Medicine, Organoid Technology, Clinical Transformation, Disease Diagnosis, Treatment, Drug Sensitivity Testing, New Drug Screening, Tumor Marker Development, Precision Medicine, Therapeutic Innovations

Frequently Asked Questions

Companies similar to Danwang Medical include ORGANOIDSCIENCES 오가노이드사이언스, Rznomics Inc., OncXerna Therapeutics , VitroScan, Olaris, Inc. They work in Biopharma and Biotechnology and share Danwang Medical's focus on precision medicine, regenerative medicine and disease diagnosis.

Bounce Watch lists 12 companies that share Danwang Medical's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Danwang Medical and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Danwang Medical Profile ORGANOIDSCIENCES 오가노이드사이언스 Alternatives Rznomics Inc. Alternatives OncXerna Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Danwang Medical on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.